ArticleFrontiers in pharmacology2023

Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysis.

Xi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.